These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24421214)

  • 1. Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial.
    Schleussner E; Lehmann T; Kähler C; Schneider U; Schlembach D; Groten T
    J Perinat Med; 2014 Jul; 42(4):507-14. PubMed ID: 24421214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trial.
    Groten T; Lehmann T; Städtler M; Komar M; Winkler JL; Condic M; Strizek B; Seeger S; Jäger Y; Pecks U; Eckmann-Scholz C; Kagan KO; Hoopmann M; von Kaisenberg CS; Brodowski L; Tauscher A; Schrey-Petersen S; Friebe-Hoffmann U; Lato K; Hübener C; Delius M; Verlohren S; Sroka D; Schlembach D; de Vries L; Kraft K; Seliger G; Schleußner E;
    Am J Obstet Gynecol; 2023 Jan; 228(1):84.e1-84.e12. PubMed ID: 35931132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Pentaerytrithyltetranitrate reduce fetal growth restriction in pregnancies complicated by uterine mal-perfusion? Study protocol of the PETN-study: a randomized controlled multicenter-trial.
    Groten T; Lehmann T; Schleußner E;
    BMC Pregnancy Childbirth; 2019 Sep; 19(1):336. PubMed ID: 31521118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentaerythrityltetranitrate (PETN) improves utero- and feto-placental Doppler parameters in pregnancies with impaired utero-placental perfusion in mid-gestation - a secondary analysis of the PETN-pilot trial.
    Bowkalow S; Schleussner E; Kähler C; Schneider U; Lehmann T; Groten T
    J Perinat Med; 2018 Nov; 46(9):1004-1009. PubMed ID: 29272253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OP002. Impact of the NO-donor pentaerythrithyltetranitrate on perinatal outcome in high-risk pregnancies: A prospective randomized double blinded pilot study.
    Dietmar S; Tanja G; Thomas L; Uwe S; Ekkehard S
    Pregnancy Hypertens; 2013 Apr; 3(2):62. PubMed ID: 26105847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentaerythrityl tetranitrate improves the outcome of children born to mothers with compromised uterine perfusion-12-months follow-up and safety data of the double-blind randomized PETN trial.
    Groten T; Lehmann T; Städtler M; Komar M; Winkler JL; Condic M; Strizek B; Seeger S; Jäger Y; Pecks U; Eckmann-Scholz C; Kagan KO; Hoopmann M; von Kaisenberg CS; Hertel B; Tauscher A; Schrey-Petersen S; Friebe-Hoffmann U; Lato K; Hübener C; Delius M; Verlohren S; Sroka D; Schlembach D; de Vries L; Kraft K; Seliger G; Schleußner E;
    Am J Obstet Gynecol MFM; 2024 Apr; 6(4):101332. PubMed ID: 38460823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OS013. Reduction of preeclampsia related complications with with theNO-donor penterythriltetranitrat (petn) in risk pregnancies - Aprospective randomized double-blind placebo pilot study.
    Groten T; Fitzgerald J; Lehmann T; Schneider U; Kähler C; Schleussner E
    Pregnancy Hypertens; 2012 Jul; 2(3):181. PubMed ID: 26105227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doppler ultrasound of the uterine artery in the prediction of severe complications during low-risk pregnancies.
    Schwarze A; Nelles I; Krapp M; Friedrich M; Schmidt W; Diedrich K; Axt-Fliedner R
    Arch Gynecol Obstet; 2005 Jan; 271(1):46-52. PubMed ID: 15185101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis.
    Bujold E; Morency AM; Roberge S; Lacasse Y; Forest JC; Giguère Y
    J Obstet Gynaecol Can; 2009 Sep; 31(9):818-826. PubMed ID: 19941706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of a placental profile in high-risk pregnancies.
    Toal M; Chan C; Fallah S; Alkazaleh F; Chaddha V; Windrim RC; Kingdom JC
    Am J Obstet Gynecol; 2007 Apr; 196(4):363.e1-7. PubMed ID: 17403424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental size and the prediction of severe early-onset intrauterine growth restriction in women with low pregnancy-associated plasma protein-A.
    Proctor LK; Toal M; Keating S; Chitayat D; Okun N; Windrim RC; Smith GC; Kingdom JC
    Ultrasound Obstet Gynecol; 2009 Sep; 34(3):274-82. PubMed ID: 19672838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus.
    Pagani G; Reggia R; Andreoli L; Prefumo F; Zatti S; Lojacono A; Tincani A; Frusca T
    Prenat Diagn; 2015 May; 35(5):447-52. PubMed ID: 25346020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic maturation of the placenta at 30 to 34 weeks is not associated with second trimester markers of placental insufficiency in low-risk pregnancies.
    Walker MG; Hindmarsh PC; Geary M; Kingdom JCP
    J Obstet Gynaecol Can; 2010 Dec; 32(12):1134-1139. PubMed ID: 21176324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.
    Ebrashy A; Ibrahim M; Marzook A; Yousef D
    Croat Med J; 2005 Oct; 46(5):826-31. PubMed ID: 16158479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-trimester uterine artery Doppler indices in the prediction of small-for-gestational age pregnancy and intrauterine growth restriction.
    Melchiorre K; Leslie K; Prefumo F; Bhide A; Thilaganathan B
    Ultrasound Obstet Gynecol; 2009 May; 33(5):524-9. PubMed ID: 19382287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
    Groom KM; David AL
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doppler assessment of the uterine and uteroplacental circulation in the second trimester in pregnancies at high risk for pre-eclampsia and/or intrauterine growth retardation: comparison and correlation between different Doppler parameters.
    Zimmermann P; Eiriö V; Koskinen J; Kujansuu E; Ranta T
    Ultrasound Obstet Gynecol; 1997 May; 9(5):330-8. PubMed ID: 9201877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic treatment for preeclampsia in high-risk teenage primigravidae with nitric oxide donors: a pilot study.
    Abdel Razik M; El-Berry S; Abosereah M; Edris Y; Sharafeldeen A
    J Matern Fetal Neonatal Med; 2016; 29(16):2617-20. PubMed ID: 26456672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doppler sonography of uterine arteries at 20-23 weeks: depth of notch gives information on probability of adverse pregnancy outcome and degree of fetal growth restriction in a low-risk population.
    Becker R; Vonk R
    Fetal Diagn Ther; 2010; 27(2):78-86. PubMed ID: 20093804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction and prevention of ischemic placental disease.
    Friedman AM; Cleary KL
    Semin Perinatol; 2014 Apr; 38(3):177-82. PubMed ID: 24836830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.